TINA REYNOLDS: Open Payments
NPI 1023273232 · ENGLEWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 25 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $355 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $135 |
| Novo Nordisk Inc | 5 | $91 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| ABBVIE INC. | 1 | $29 |
| Lilly USA, LLC | 2 | $28 |
| MicroTransponder, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
| PFIZER INC. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 2 | $14 |
Products named: OTEZLA, Ozempic, AIRSUPRA, QULIPTA, MOUNJARO, REPATHA, Veozah, PAXLOVID.
Industry payments across FL — which companies pay providers there.
